SCHEMBL19995584

SCHEMBL19995584

CNC(=S)N1CC[C@@H](c2cc(F)cc(F)c2)C1

nearest known ligand 0.59

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 9/20 0.59
NPC1 O15118 6/20 0.59
SMN1; SMN2 Q16637 3/20 0.59
HTT P42858 3/20 0.47
ALDH1A1 P00352 2/20 0.47
GAA P10253 2/20 0.44
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
MAPT P10636 2/20 0.42
NFKB1 P19838 1/20 0.42
NFKB2 Q00653 1/20 0.42
RELA Q04206 1/20 0.42
POLB P06746 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19995563 1.00 RAB9A (0.59) RAB9ANPC1SMN1; SMN2HTTALDH1A1
SCHEMBL19995535 0.80 RAB9A (0.52) RAB9ANPC1SMN1; SMN2HTTALDH1A1
SCHEMBL19995521 0.80 RAB9A (0.52) RAB9ANPC1SMN1; SMN2HTTALDH1A1
SCHEMBL19995557 0.80 RAB9A (0.52) RAB9ANPC1SMN1; SMN2HTTALDH1A1
SCHEMBL19995974 0.79 RAB9A (0.63) RAB9ANPC1SMN1; SMN2HTTALDH1A1
SCHEMBL19995523 0.79 RAB9A (0.63) RAB9ANPC1SMN1; SMN2HTTALDH1A1
SCHEMBL20006124 0.78 RAB9A (0.43) RAB9ANPC1SMN1; SMN2HTTALDH1A1
SCHEMBL19995568 0.78 RAB9A (0.43) RAB9ANPC1SMN1; SMN2HTTALDH1A1
SCHEMBL19995888 0.73 MEN1 (0.38) RAB9ANPC1SMN1; SMN2ALDH1A1MEN1
SCHEMBL19996130 0.71 MEN1 (0.41) RAB9ANPC1SMN1; SMN2HTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3515433-A1 BLOOD-BRAIN BARRIER-PENETRANT DOPAMINE-B-HYDROXYLASE INHIBITORS BIAL - PORTELA & Cª, S.A. (PT) 2019-07-31 EP disclosed
WO-2018056854-A1 BLOOD-BRAIN BARRIER-PENETRANT DOPAMINE-B-HYDROXYLASE INHIBITORS BIAL - PORTELA & Cª, S.A. (PT) 2018-03-29 WO disclosed